News日前,由中国基金报主办的“2025中国上市公司英华示范案例评选暨最受机构投资者喜爱的上市公司评选”结果正式揭晓。三生制药(股票代码:01530.HK)凭借其稳健的公司治理和前瞻性的创新战略布局,斩获“港股价值示范案例”奖项,成为港股市场中兼具成长性与投资价值的典范企业。2025中国上市公司英华示范案例评选旨在促进中国资本市场高质量发展,倡导价值投资、长期投资导向,发掘中国价值,传递中国声音...
Source LinkNews日前,由中国基金报主办的“2025中国上市公司英华示范案例评选暨最受机构投资者喜爱的上市公司评选”结果正式揭晓。三生制药(股票代码:01530.HK)凭借其稳健的公司治理和前瞻性的创新战略布局,斩获“港股价值示范案例”奖项,成为港股市场中兼具成长性与投资价值的典范企业。2025中国上市公司英华示范案例评选旨在促进中国资本市场高质量发展,倡导价值投资、长期投资导向,发掘中国价值,传递中国声音...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.